Re-Pharm - Articles and news items

Re-Pharm awarded patent for re-purposed compound RP0217

Industry news / 27 November 2015 / Victoria White

This patent protects the topical use of RP0217 for the treatment or prevention of respiratory and gastrointestinal inflammatory disorders…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+